ArchiMed

ArchiMed stands as a distinguished investment organization dedicated solely to the healthcare sector, with a strategic presence spanning Europe, North America, and Asia-Pacific regions. The firm brings together a unique blend of operational, medical, scientific, and financial expertise, positioning itself as both a strategic advisor and financial backer to healthcare enterprises. With approximately €8 billion under management across its fund portfolio, ArchiMed has established itself as the manager of Europe's largest healthcare-focused private equity fund created by a European-based General Partner.

The investment strategy of ArchiMed encompasses a diverse range of healthcare subsectors, including Biopharma Products, Consumer Health, Animal & Environmental Health, Healthcare IT, Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services. This comprehensive approach allows the firm to identify promising opportunities across the healthcare ecosystem while leveraging cross-sector insights. ArchiMed typically targets companies with strong growth potential that can benefit from the firm's extensive industry connections, operational expertise, and capital resources to accelerate their development trajectories.

ArchiMed delivers substantial value to its portfolio companies by facilitating international expansion, orchestrating strategic acquisitions, fostering innovation, and broadening product and service offerings. The firm's global network and deep industry knowledge enable portfolio companies to navigate complex regulatory environments, access new markets, and implement best practices across operations. ArchiMed's investment professionals work closely with management teams to develop and execute customized growth strategies tailored to each company's unique market position and capabilities.

Since its founding, ArchiMed has maintained a strong commitment to Impact investing, integrating environmental, social, and governance (ESG) considerations throughout its investment process. This dedication is expressed both through direct investment activities and through initiatives of its EURÊKA Foundation, which supports healthcare innovation and accessibility. The firm's impact-oriented approach aligns with growing investor demand for responsible investment opportunities while addressing critical healthcare challenges such as improving patient outcomes, enhancing healthcare access, and developing sustainable healthcare solutions for underserved populations.